Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Inhibition of human immunodeficiency virus type 1 Env-mediated fusion by DC-SIGN.

Nobile C, Moris A, Porrot F, Sol-Foulon N, Schwartz O.

J Virol. 2003 May;77(9):5313-23.

2.

DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells.

Ceccaldi PE, Delebecque F, Prevost MC, Moris A, Abastado JP, Gessain A, Schwartz O, Ozden S.

J Virol. 2006 May;80(10):4771-80.

3.

Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.

Burleigh L, Lozach PY, Schiffer C, Staropoli I, Pezo V, Porrot F, Canque B, Virelizier JL, Arenzana-Seisdedos F, Amara A.

J Virol. 2006 Mar;80(6):2949-57.

4.

Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes.

Nobile C, Petit C, Moris A, Skrabal K, Abastado JP, Mammano F, Schwartz O.

J Virol. 2005 May;79(9):5386-99.

5.

DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells.

Arrighi JF, Pion M, Garcia E, Escola JM, van Kooyk Y, Geijtenbeek TB, Piguet V.

J Exp Med. 2004 Nov 15;200(10):1279-88.

6.

Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells.

Arrighi JF, Pion M, Wiznerowicz M, Geijtenbeek TB, Garcia E, Abraham S, Leuba F, Dutoit V, Ducrey-Rundquist O, van Kooyk Y, Trono D, Piguet V.

J Virol. 2004 Oct;78(20):10848-55.

7.

Interactions of LSECtin and DC-SIGN/DC-SIGNR with viral ligands: Differential pH dependence, internalization and virion binding.

Gramberg T, Soilleux E, Fisch T, Lalor PF, Hofmann H, Wheeldon S, Cotterill A, Wegele A, Winkler T, Adams DH, Pöhlmann S.

Virology. 2008 Mar 30;373(1):189-201. Epub 2008 Feb 20.

8.
9.
10.

DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation.

Moris A, Nobile C, Buseyne F, Porrot F, Abastado JP, Schwartz O.

Blood. 2004 Apr 1;103(7):2648-54. Epub 2003 Oct 23.

11.

Bile salt-stimulated lipase from human milk binds DC-SIGN and inhibits human immunodeficiency virus type 1 transfer to CD4+ T cells.

Naarding MA, Dirac AM, Ludwig IS, Speijer D, Lindquist S, Vestman EL, Stax MJ, Geijtenbeek TB, Pollakis G, Hernell O, Paxton WA.

Antimicrob Agents Chemother. 2006 Oct;50(10):3367-74.

13.

CD4 coexpression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1.

Wang JH, Janas AM, Olson WJ, KewalRamani VN, Wu L.

J Virol. 2007 Mar;81(5):2497-507. Epub 2006 Dec 6.

14.

cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor.

Lee B, Leslie G, Soilleux E, O'Doherty U, Baik S, Levroney E, Flummerfelt K, Swiggard W, Coleman N, Malim M, Doms RW.

J Virol. 2001 Dec;75(24):12028-38.

15.

Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes.

Naarding MA, Ludwig IS, Groot F, Berkhout B, Geijtenbeek TB, Pollakis G, Paxton WA.

J Clin Invest. 2005 Nov;115(11):3256-64. Epub 2005 Oct 20.

16.

Cell type-dependent retention and transmission of HIV-1 by DC-SIGN.

Trumpfheller C, Park CG, Finke J, Steinman RM, Granelli-Piperno A.

Int Immunol. 2003 Feb;15(2):289-98.

PMID:
12578859
18.

Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes.

van Montfort T, Nabatov AA, Geijtenbeek TB, Pollakis G, Paxton WA.

J Immunol. 2007 Mar 1;178(5):3177-85.

19.
20.

Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression.

Borggren M, Repits J, Kuylenstierna C, Sterjovski J, Churchill MJ, Purcell DF, Karlsson A, Albert J, Gorry PR, Jansson M.

Retrovirology. 2008 Mar 27;5:28. doi: 10.1186/1742-4690-5-28.

Supplemental Content

Support Center